Title of article :
Oral allopurinol desensitization
Author/Authors :
Kolahi ، Sousan نويسنده , , Tajeddini، Mahdi نويسنده 1Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran Tajeddini, Mahdi , Jalilzadeh Binazar، Mehran نويسنده Student Research Center, Tabriz University of Medical Sciences, Tabriz, Iran Jalilzadeh Binazar, Mehran
Issue Information :
روزنامه با شماره پیاپی سال 2014
Pages :
2
From page :
32
To page :
33
Abstract :
Allopurinol, a xanthine oxidase inhibitor, is an effective urate-lowering drug. Unlike majority of patients tolerate allopurinol well, in 2% of patients receiving allopurinol, hypersensitivity reactions have been reported. In this case a 71-year-old woman with tophaceous gout since 10 years ago, presented to our rheumatology clinic. Because of occurring hypersensitivity reactions, allopurinol was discontinued and disease worsened despite administration of colchicine. She was admitted several times due to flare up of gout. Other forms of allopurinol are not available in Iran, so we decided to conduct an allopurinol desensitization protocol with tablets form. Side effects have not been reported yet.
Journal title :
Journal of Case Reports in Practice (JCRP)
Serial Year :
2014
Journal title :
Journal of Case Reports in Practice (JCRP)
Record number :
1026366
Link To Document :
بازگشت